Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)

Kapil Suchal, Salma Malik, Nanda Gamad, Rajiv Kumar Malhotra, Sameer N. Goyal, Uma Chaudhary, Jagriti Bhatia, Shreesh Ojha, Dharamvir Singh Arya

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the article titled "Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury"[1], it was identified that the beta-actin panels in Figures 4(a), 4(b), and 4(c) were identical. With the agreement of the editor, a revised version of Figure 4 is being provided with the data from a repeat of the experiment. The authors apologize for this error in the original publication.

Original languageEnglish
Article number4530278
JournalOxidative medicine and cellular longevity
Volume2020
DOIs
Publication statusPublished - 2020

ASJC Scopus subject areas

  • Biochemistry
  • Ageing
  • Cell Biology

Fingerprint

Dive into the research topics of 'Erratum: Kaempferol attenuates myocardial ischemic injury via inhibition of MAPK signaling pathway in experimental model of myocardial ischemia-reperfusion injury (Oxidative Medicine and Cellular Longevity (2016) 2016 (7580731) DOI: 10.1155/2016/7580731)'. Together they form a unique fingerprint.

Cite this